Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Piper Sandler analyst David Amsellem initiated coverage on Pelthos Therapeutics Inc (AMEX:PTHS) with an Overweight rating and announced a price target of $48. Pelthos Therapeutics shares closed at $23.00 on Thursday. See how other analysts view this stock.
• Barclays analyst Etzer Darout initiated coverage on Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) with an Overweight rating and announced a price target of $224. Jazz Pharmaceuticals shares closed at $188.97 on Thursday. See how other analysts view this stock.
• Rosenblatt analyst John McPeake initiated coverage on Palantir Technologies Inc. (NASDAQ:PLTR) with a Buy rating and announced a price target of $150. Palantir shares closed at $135.94 on Thursday. See how other analysts view this stock.

Considering buying JAZZ stock? Here’s what analysts think:

Photo: Shutterstock

• No comments yet. Be the first to comment!